Company / Cost of Revenue
Danaher Corporation Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$10.0B
FY2025
5-year range
$7.9B / $10.0B
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
#12 of 113
Health Care
What the data says
Danaher Corporation's cost of revenue of $10.0B is higher than 89% of companies in the Health Care sector (FY2025). Cost of Revenue has fluctuated over the past 10 years, ranging from $6.9B in FY2017 to $10.0B in FY2025.
Based on SEC 10-K filings.
$10.0B in FY2025 with a 5-year CAGR of +5.9%. Top quartile in the Health Care sector.
Increased from $9.6B to $10.0B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +0.8%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Sector benchmark
-11.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.9%, indicating consistent growth.
- In FY2025, cost of revenue increased 3.9% year-over-year.
- Ranks #12 out of 113 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.0B | +3.9% |
| FY2024 | $9.7B | +1.1% |
| FY2023 | $9.6B | -2.5% |
| FY2022 | $9.8B | +23.7% |
| FY2021 | $7.9B | +5.1% |
| FY2020 | $7.5B | -4.8% |
| FY2019 | $7.9B | +5.1% |
| FY2018 | $7.5B | +8.6% |
| FY2017 | $6.9B | -8.0% |
| FY2016 | $7.5B | +13.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026